Picture of Shin Nippon Biomedical Laboratories logo

2395 — Shin Nippon Biomedical Laboratories News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Table: Shin Nippon Biomedical -9-MTH group results

Feb 14 (Reuters)-  
             Shin Nippon Biomedical Laboratories Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended        Year to   
                Dec 31, 2016        Dec 31, 2015      Mar 31, 2017   
                   LATEST             YEAR-AGO           LATEST      
                   RESULTS             RESULTS          FORECAST     
  Sales             11.55               10.42             16.50      
                 (+10.8 pct)         (-17.4 pct)       (+11.9 pct)   
  Operating       loss 2.10           loss 3.27         loss 2.25    
  Recurring       loss 1.83           loss 3.89         loss 2.78    
  Net             loss 1.78              2.68           loss 2.92    
  EPS          loss 43.33 yen         67.47 yen      loss 70.72 yen  
  Ann Div                                NIL                         
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL                         
   
  NOTE - Shin Nippon Biomedical Laboratories Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Shin Nippon Biomedical Laboratories

See all news